Archived Releases

April 2, 2019
Foamix Announces Settlement of Litigation with Perrigo Relating to Finacea Foam
REHOVOT, Israel and BRIDGEWATER, N.J. , April 02, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix” or the “Company”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in
February 28, 2019
Foamix Reports Fiscal Year 2018 Financial Results and Provides Corporate Update
Conference Call Scheduled for Friday, March 1 at 8:30am Eastern Time REHOVOT, Israel and BRIDGEWATER, N.J. , Feb. 28, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company focused on
Displaying 1 - 10 of 159